Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (18048)	1/22/1999 3:01:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, Apparently revenue growth and other fundamentals do not matter. IMO the only think that will help Vivus share price will be a return of institutional investors. The day traders won't help unless there is a significant momentum change to the upside. who would want to buy this stock when you can buy Amazon.crap or Yahoo.insanely evaluated for a quick intraday 10 point gain.

To: Mkilloran who wrote (18048)	1/22/1999 3:33:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

martin, Here is something to look forward to....... As Astra/Zeneca launches its release of MUSE in Europe, the publicity/exposure to a much safer and local alternative to Viagra should bring European investors into Vivus. The Europeans tend to be much more value oriented as opposed to momentum traders.